Diabetic muscle infarction in a 57 year old male: a case report by Ivan V Litvinov et al.
Litvinov et al. BMC Research Notes 2012, 5:701
http://www.biomedcentral.com/1756-0500/5/701CASE REPORT Open AccessDiabetic muscle infarction in a 57 year old male:
a case report
Ivan V Litvinov1, Arnold Radu2 and Natasha Garfield3*Abstract
Background: Diabetic muscle infarction is a rare complication of diabetes mellitus (DM) and is often misdiagnosed
as cellulitis. This complication is usually associated with poor disease prognosis and high mortality with previous
studies reporting a risk of 50% recurrence or another macrovascular complication occurring within one year. Thus,
there needs to be greater awareness of this complication of diabetes.
Case presentation: In the current work, we present a case report and literature review of DMI occurring in a calf of
a 57 year old male. However, unlike the suspected trend, our patient has performed well after this incident and has
not sustained another macrovascular event now > 15 month since his original diabetic muscle infarction.
Conclusion: Even though diabetic muscle infarction is an uncommon condition, it is important to consider this
diagnosis in a diabetic patient. We hope that our findings and literature review will aid clinicians to better diagnose
and manage this condition.
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Diabetic muscle infarction (DMI), also known as diabetic
myonecrosis, is a rare complication of diabetes mellitus
(DM) and is usually associated with poor disease prog-
nosis and high mortality [1,2]. It is often defined as
spontaneous ischemic necrosis of skeletal muscle that is
unrelated to atheroembolism or occlusion of major ar-
teries [2,3]. The exact prevalence of this condition is not
known. A systematic review of the literature from incep-
tion to August 2001 identified at total 47 reports de-
scribing 166 episodes of DMI [2]. Usually this condition
develops with approximate equal frequency in males and
females [1,2]. Established risk factors for acquiring a
DMI include long-standing DM, insulin dependent type
I DM, poor control of glycemia and presence of micro-
vascular diabetic complications (neuropathy, retinop-
athy, nephropathy) [1,2,4].
Usually, patients present with an acute onset of painful
swelling of the thigh (80%), or less commonly the calf
(20%), that then evolves over days or weeks [1,2]. Bilateral
involvement may occur in ~1/3 of all patients. Rarely a* Correspondence: natasha.garfield@muhc.mcgill.ca
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Fever may be present in 10% cases [1,2]. History of present
illness often reveals no trauma or preceding infection. In
these patients, even if a DMI is suspected it is critical to
rule out pyomyositis, spontaneous gangrenous myositis,
clostridial myonecrosis, necrotizing fasciitis and venous
thrombosis. It is of notice that diabetic patients are believed
to be at increased risk for many of the above conditions
[5,6]. A diagnosis of intramuscular hematoma should be
considered in patients taking anticoagulation therapy and a
possibility of calciphylaxis should be entertained in patients
with underlying renal failure. Finally, even though a tumor
of the muscle is unlikely to be mistaken for DMI, infarction
of a tumor may have a similar presentation.
As evident from above, DMI is in part a diagnosis of
exclusion that can be supported by imaging and muscle
biopsy. On MRI, one often sees on T2-weighted sequences
high intensity signal in the involved muscle, subcutaneous
edema and subfascial fluid [1,7-10]. Loss of the normal
fatty intramuscular septa is also a common sign of a DMI
[1,7-10]. Use of gadolinium in imaging may help distin-
guish nonenhancing infarcted muscle from surrounding
inflammation or edema [1,7-10]. Other imaging modalities
including, computer tomography or arteriography are
often non-diagnostic and have limited use in confirming al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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venous thromboembolic event, but is not suitable to dis-
tinguish between abscess formation and a DMI. Explor-
ation or core muscle biopsy is often performed to support
the diagnosis of a DMI and usually shows muscle necrosis,
edema and/or occlusion of arterioles and capillaries by
fibrin [2].
Few studies have attempted to investigate possible
treatment and secondary prevention options for DMIs
[1,11]. Unfortunately, currently no unified consensus
exists. One retrospective analysis evaluated three pos-
sible therapies, which included bed rest and analgesia vs.
antiplatelet agents and/or anti-inflammatory medications
with rest and analgesia vs. surgical excision of necrotic
tissue [1]. The authors report that time to recovery was
the shortest when antiplatelet/non-steroidal anti inflam-
matory (NSAID) agents were used (5 weeks to recovery),
while surgical excision correlated with the longest time
to recovery (13 weeks). Rest, analgesia and supportive
therapy alone yielded intermediate results (8 weeks to
recovery). Overall, based on the reviewed literature,
there appears to be a trend towards use of small dose of
aspirin (80 mg per day) to prevent recurrence of a DMI
or other macrovascular complications. NSAIDs are often
avoided in these patients due to high risk of precipitating
acute kidney injury.
Finally, the benefits of physiotherapy were examined
in one study that suggested that straining the involved
leg may prolong recovery [12]. However, regular daily
activity did not lead to disease exacerbation [12]. Unfor-
tunately, the prognosis for this rare complication of dia-
betes remains grim with only few patients surviving
longer than a year free of another major macrovascularFigure 1 Selected axial (A) and coronal (B) computer tomography sca
irregular hypo dense area (arrows) within the medial gastrocnemius m
peripheral enhancement and intramuscular gas suggests that this area mayevent such as myocardial infarction or a stroke [13].
Furthermore, many patients develop a recurrence of a
DMI, with ~50% of cases occurring on a contralateral
side [1,2].
In the current report, we describe a case of DMI in a
57 year old male with long standing poorly controlled
diabetes. This case highlights clinical and radiological
findings that are important in recognising and managing
this condition.
Case presentation
A 57 year old male with 8-year history of poorly con-
trolled Type 2 DM, hypertension, two previous episodes
of transient ischemic attacks and underlying cirrhosis of
the liver secondary hepatitis C and alcohol abuse pre-
sented to our hospital with a two-day history of “not
being able to walk”. He reports that his symptoms
started about 2 months ago, when one morning he was
awoken with a sudden onset of right calf pain, erythema
and swelling. He reported his complaints to a family
physician, who unsuccessfully treated him with various
courses of antibiotics. His pain gradually progressed,
until 1 day prior to admission, when he realized that he
was no longer able to weight bear on his affected leg.
The patient denied any history of fever, trauma, animal
bites or infection. Initial work up revealed moderate
leukocytosis (white blood count of 14.7 × 10^9 cells/L),
normal electrolytes and unremarkable liver function
tests. Interestingly, at the time of presentation this pa-
tient had normal creatinine kinase (20 U/L), which sug-
gests that the majority of tissue injury occurred during
the preceding days to weeks prior to admission. On
presentation, the patient had a blood glucose reading ofn images with intravenous contrast demonstrating an ill-defined
uscle extending from the knee to the mid-calf. The absence of
represent an abscess.
Figure 2 Selected axial (A) and sagittal (B) magnetic resonance images demonstrating two longitudinal hyper intense collections
(1 and 2) within the medial gastrocnemius muscle. The hyper intense signal of the non-necrotic portions in the gastrocnemius and soleus
muscles is indicative of inflammatory changes and edema.
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Spot urine albumin/creatinin ratio documented signifi-
cant microalbuminuria Additional diabetic workup failed
to reveal any signs of retinopathy or neuropathy.
Blood cultures were obtained and the patient was started
empirically on broad spectrum antibiotics. Deep vein
thrombosis was ruled out by doppler ultrasound study of
both legs. Unfortunately, antibiotic therapy failed to control
his symptoms. Subsequently, his cultures showed no bac-
terial growth and, hence, all antibiotic medications were
discontinued. Initial computer tomography imaging of
both legs failed to reveal any signs of infection or abscess,
but was suggestive of DMI (Figure 1).
While in hospital, glycemic control was established
with intravenous and subcutaneous insulin therapy, pain
was controlled with analgesic medication and bed rest.
Subsequent MRI revealed significant edema, inflamma-
tion, necrosis of gastrocnemious and soleus muscles and
identified a number of associated communicating fluid
collections, that were deemed to be at high risk of be-
coming infected (Figure 2). There was no evidence of ar-
terial thromboembolism. Due to the presence of fluid
collections that were deemed to be at high risk of be-
coming infected, plastic surgery service was consulted
and wound debridement was performed. Pathological
analysis of debris obtained from soleus and gastrocne-
mius muscles revealed necrotic tissue with signs of se-
vere acute and chronic inflammation (data not shown).
Bacterial and fungal stains and cultures for these tissues
did not reveal any infectious agents. The patient grad-
ually recovered over the period of ~4 weeks in the hos-
pital with supportive therapy and was discharged to a
rehabilitation facility on insulin, clopidogrel and Aspirin(80 mg per day). He had no further complications on his
15 months follow up visit and is followed regularly in
our diabetic clinic.
Conclusion
In summary, we presented a case of DMI in Type 2 dia-
betic patient, who presented with right calf involvement,
but performed significantly better then expected with re-
spect to his diabetes progression. Even though DMI is
an uncommon condition, it is important to consider this
diagnosis in a diabetic patient. Presence of the aforemen-
tioned risk factors and lack of response to antibiotics
may play an important role in establishing a diagnosis.
We hope that our findings and literature review will aid
clinicians to better diagnose and manage this condition.
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